News Focus
News Focus
Followers 10
Posts 480
Boards Moderated 0
Alias Born 02/10/2006

Re: DewDiligence post# 3838

Thursday, 06/16/2011 9:18:52 AM

Thursday, June 16, 2011 9:18:52 AM

Post# of 20689
Thanks

Saw $300 million reiterated in Rocky's recap in message 3822. A bout the only thing I had some differences with was his take on the investor reaction to Palo Alto's anti dilution speech. I did not hear any strong opposition from investors to the idea of a buyback. Since I think there were only about 5 us there it must have been some conversations from his row rather than an open question or comment.

I would support MNTA offsetting the granting of options by buying a commensurate number of shares as long as their cash flow allows them to do so. Palo alto indicated that they have been in discussions with MNTA for several months on this issue, so I think this was an attempt to rally other shareholders. They probably started about August last year.

I thought CW gave a very general answer to my question regarding the denial of the Teva citizens petition. I thought it would be an opportunity for him to state that the decision had not been delayed, it had been denied. He chose to speak to the broader Teva spin efforts rather than the substance of the CP denial. You could tell that he thought that the whole matter of the Teva spin machine was humorous.

I thought the GS discussion of the price increases in the MS market was interesting but it was not reiterated at the Annual meeting. I think Teva garnered quite a bit of ill will with the last round of price increases for copax. Obviously it was not limited to them and was an attempt to stabilize revs after Gilenya entered the market. His comments at GS definitely indicated that a generic drug in this space is highly awaited. I think it will not be hard to ramp sales once m-copax enters the market.


FL